OSF Ventures, the corporate venturing arm of US-based healthcare provider OSF HealthCare, has launched its second fund, which will be equipped with $75m.
The unit invests in early-stage developers of healthcare IT, medical devices, care services, diagnostics equipment and other healthcare technology-enabled products.
To date, OSF Ventures has provided funding for 15 companies, as well as funds managed by Ascension Ventures, the corporate venture capital vehicle formed by care provider Ascension Health, and VC platform LRV Health.
OSF said it is close to completing the fund’s next investment but did not disclose the company. The new fund is the same size as OSF’s inaugural vehicle, which launched with $75m in limited partner commitments in 2016.
The unit’s portfolio includes oncology testing technology producer Paradigm Diagnostics, healthcare data services provider Health Catalyst, surgery technology developer Gauss Surgical and blood-flow system developer Endotronix.
Michelle Conger, OSF HealthCare’s chief strategy officer, said: “The Ventures team brings an understanding of the changing landscape, and introductions to emerging technologies as we ramp up our work in areas such as digital transformation, the deployment of advanced analytics and adoption of precision medicine platforms.”